Tag: Kenneth Ataga


Kenneth Ataga, MD, Co-Authors Paper on Potential New Treatment for Sickle Cell Disease

|

Newly published results from a multinational study co-authored by Kenneth Ataga, MD, director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) and the Memphis Consortium for Sickle Cell Disease and Non-Malignant Hematology Research, indicated voxelotor, a novel experimental drug for sickle cell disease, reduced anemia and boosted… Read More


Kenneth Ataga Named Director of New UTHSC Center for Sickle Cell Disease

|

Kenneth Ataga, MD, has been named director of the University of Tennessee Health Science Center’s new Center for Sickle Cell Disease in the College of Medicine. He will begin his new role July 1. The UTHSC Center for Sickle Cell Disease is a collaborative effort among UTHSC, West Cancer Center, UT-Methodist University Hospital and Regional… Read More